CellProthera is funded by public and private investors. Since its foundation in 2008 the company has raised € 1.6 million during the seeding phase. CellProthera chose this financing strategy because our private investors share the same values, are knowledgeable about cell therapy, set the company demanding milestones and are supportive of our goals.
Detailed reporting about the company’s progress is made regularly to our shareholders. Investors interested in the company should please contact us at email@example.com